title: Phenotypic variability (heterogeneity) of peroxisomal disorders.
abstract: Peroxisomes perform a multitude of biosynthetic and catabolic functions, many of which are related to lipid metabolism. Peroxisomal disorders result either from deficiency of a single peroxisomal enzyme or protein, or from a defect in the complex mechanism of peroxisomal biogenesis, resulting in deficiency of several or multiple peroxisomal functions. These can be assessed by a battery of biochemical assays, enabling a biochemical phenotype to be defined that is specific and diagnostic for each of the peroxisomal disorders. Some peroxisomal disorders have unique and specific clinical phenotypes, which may be diagnostic. Others share patterns of clinical abnormalities (particularly neurological dysfunction, craniofacial dysmorphism, skeletal defects, sensory deafness, retinopathy) consistent with defined clinical phenotypes, but with considerable overlap and heterogeneity. To a certain extent, the clinical features of a particular disorder reflect the accumulation or deficiency of specific metabolites. Thus, the same clinical phenotypes may be caused by both single enzyme defects and PBDs. Furthermore, the same defect may present with different clinical phenotypes. In general, the severity of the clinical phenotype correlates with the degree of biochemical dysfunction. The clinical heterogeneity of peroxisomal disorders constitutes a diagnostic challenge demanding a high index of suspicion on the clinician's part.
authors.affiliation: Metabolic Disease Unit, Department of Pediatrics, Rambam Medical Center, Technion-Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, Haifa, Israel. h_mandel@rambam.health.gov.il
authors.forename: Hanna
authors.initials: H
authors.lastname: Mandel
authors.forename: Stanley H
authors.initials: SH
authors.lastname: Korman
mesh_terms: D018902:Chondrodysplasia Punctata, Rhizomelic / Q000235:genetics / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D010084:Oxidation-Reduction; D018901:Peroxisomal Disorders / Q000145:classification / Q000235:genetics* / Q000378:metabolism*; D010641:Phenotype; D010955:Plasmalogens / Q000096:biosynthesis; D015211:Zellweger Syndrome / Q000235:genetics / Q000378:metabolism
chemical_list: D005227:Fatty Acids; D010955:Plasmalogens